Mengmeng Jiang

A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.

Jia Liu, Ping Li, Xin Chen, 2021, International immunopharmacology.

Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation

G. Wang, Zhaobing Gao, Qing Zhang, 2022, Theranostics.

MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2

Ping Li, Hui Li, Huanhuan He, 2022, Journal for immunotherapy of cancer.

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts

L. Montaner, Xin Chen, Jin Wang, 2020, Journal of leukocyte biology.

TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments

Md. Sahidul Islam, Yiru Wang, Xin Chen, 2023, Frontiers in Immunology.

Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells

Md. Sahidul Islam, C. Chou, Xin Chen, 2020, Science Advances.

TNFR2 deficiency impairs the growth of mouse colon cancer

C. Chou, Xin Chen, Xinyu Yang, 2023, International journal of biological sciences.

Therapeutic potential of TNFR2 agonists: a mechanistic perspective

Xin Chen, Yibo Chen, Mengmeng Jiang, 2023, Frontiers in immunology.